In September a gaggle of medical groups will release guidelines for doctors on the treatment of congenital adrenal hyperplasia, a condition affecting 1 in 15,000 newborns that may result in girls being born with ambiguous/intersex genitalia (among other things), and the increasing use of the hormone treatment dexamethasone that’s shown to eliminate the chances these female babies will be gay or exhibit masculine characteristics. So that should get everyone on the same page!
Interestingly, “Carriers of the gene mutation that causes this form of hyperplasia have roughly a 12.5% chance of having a daughter with the condition. The hormone treatment must be started as soon as possible, before the gender of the child is determined, for it to have an effect on genital development.”
And while no medical group appears ready to recommend research on the drug stop (medical types would never discourage this, of course), it seems like a slippery slope that will lead to the drug, or a variant, being used on boys to cure their homosexuality before they leave the womb.